Navigation Links
Protein finding could lead to treatment for inflammatory diseases

A protein that undesirably shields a skin poxvirus from the immune system may become the key ingredient in a new topical treatment for inflammatory diseases, say medical researchers at the University of Illinois at Urbana-Champaign.

In a study appearing this month in the Journal of Virology, the scientists revealed both the function of the protein (MC160) and how it works on a molecular level to inhibit inflammatory responses.

MC160 is so named because it was the 160th gene of the molluscum contagiosum virus (MCV) sequence. "This is a really important protein for a couple of reasons," said Joanna L. Shisler, a professor of microbiology in the U. of I. College of Medicine at Urbana-Champaign who studies poxviruses.

"MC160 first piqued our curiosity because it has a homologue in humans and in herpes viruses, and each of these homologues regulate NF-kappaB" she said. NF-kB is a cellular transcription factor that activates the expression of genes involved in inflammation. Shisler's lab was interested in determining whether MC160 also acted on NF-kB.

In their study -- funded by the National Institutes of Health -- Shisler and Daniel Brian Nichols, a doctoral student in microbiology, treated human embryonic kidney cells with cytokines known to activate NF-kB. Cytokines are chemicals made by immune cells that boost the immune system by stimulating inflammation to fight infectious pathogens.

"We found that the NF-kB levels were always lower in MC160-expressing cells," Shisler said. "This was an exciting new finding because no one had previously found a function for MC160. Currently, Brian and I think that this protein's role is to inhibit NF-kB activation in MCV-infected skin cells, to prevent cytokines from boosting the immune system. MC160 is probably helping the virus persist."

Upon further examination, Shisler and Nichols discovered that MC160 shuts down the NF-kB-triggered inflammatory response by degrading a subunit of t
'"/>

Source:University of Illinois at Urbana-Champaign


Page: 1 2 3

Related biology news :

1. Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants
2. Protein discovery could unlock the secret to better TB treatment
3. Researchers Uncover Key Step In Manufacture of Memory Protein
4. An HIV Protein Plays a Surprising Role in Gene Activation
5. Protein Packages Found To Activate Genes; May Be What Regulates Development And Disease
6. New SARS Protein Linked To Important Cell Doorway
7. The Shapes Of Life: NIGMS Project Yields More Than 1,000 Protein Structures
8. PANTHER Protein Classification System Database 5.0
9. Duke Chemists Isolating Individual Molecules Of Toxic Protein In Alzheimers, Parkinsons Disease
10. Newly Discovered Compound Blocks Known Cancer-Causing Protein
11. UF Researchers Map Bacterial Proteins That Cause Tooth Loss

Post Your Comments:
(Date:11/23/2009)...gton, CT Current research suggests that a common ... The related report by Nichols et al, "Unique Lipi...lass of TLR2 Ligands Capable of Enhancing Autoimmu...American Journal of Pathology . , Multiple scler...ks the brain and spinal cord, affects nearly 1 in ...
(Date:11/23/2009)..., Iowa - The only swine vaccine available for the ... infected with the virus. The vaccination marks th... diagnosed with the pandemic flu., Iowa State Un...e, developed the vaccine this summer and has been ...wa, Kansas and Illinois for several weeks., The ...
(Date:11/23/2009)...N, WI, November 16, 2009 -- A USDOE and USDA study... idle cropland, and cropland pasture could be conv...nial grasses, such as switchgrass, from which biom...ock. Economically viable production of a perennial...es of biomass are removed annually is expected to ...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Switchgrass produces biomass efficiently 2Labopharm amends debt facility agreement with Hercules 50014 1Labopharm amends debt facility agreement with Hercules 50014 2Labopharm amends debt facility agreement with Hercules 50014 3Richard A Meier Appointed to STAAR Surgical Board of Directors 50011 1Richard A Meier Appointed to STAAR Surgical Board of Directors 50011 2Richard A Meier Appointed to STAAR Surgical Board of Directors 50011 3Richard A Meier Appointed to STAAR Surgical Board of Directors 50011 4OptoElectronix Offers Lighting Manufacturers A Unique Integrated LED Light Engine With 1 000 Lumens Light Output 50007 1OptoElectronix Offers Lighting Manufacturers A Unique Integrated LED Light Engine With 1 000 Lumens Light Output 50007 2OptoElectronix Offers Lighting Manufacturers A Unique Integrated LED Light Engine With 1 000 Lumens Light Output 50007 3
...To help improve the success of oyster restoration ...and Center for Environmental Science researcher Dr...in a new in-depth study to determine when oysters ...ver. Her team,s research is supported by a $750,00...dation. , Working with fellow UMCES Horn Point La...
...f women with breast cancer today are candidates fo... their breast tissue. Results of a UC Davis study,... recurs in the same breast are treated with a seco...rrent treatment recommendations and cutting the nu... were surprised to find that so many women in our ...
..., the oil industry will need more refined tools fo...before taken place, geologists say. , One such to...ment-on-the-move is deposited), derived from sedim... ago, scientists report in this week,s issue of th... entire Paleozoic Era. , "The new Paleozoic sea-l...
Other Biology News:Second lumpectomy for breast cancer reduces survival rates 2Paleozoic 'sediment curve' provides new tool for tracking sea-floor sediment movements 2
(Date:11/25/2009)... BEIJING, Nov. 25 /PRNewswire-Asia/ -- Sinovac B...er of vaccines, announced today that it executed,a... (Dalian) Vaccine,Technology Co., Ltd. (Sinovac Da...commercialize human-use vaccines. Sinovac will con... and commercializing world-class vaccines; the,oth...
(Date:11/24/2009)... Ambassador to also Visit Detroit , ...Who: David Appia, French Ambassador for Internatio... in France Agency, , , , ,What: Ambassador Appia ...pro-business initiatives adopted by France to furt...dscape for innovation and development., , ,When: A...
(Date:11/24/2009)...OUIS, Nov. 24 Sigma-Aldr...g at the NASDAQ OMX conference on Tuesday, Decembe...terested parties may listen via live audio broadca... tor.sig m a a ldrich.com/ . Users can clic... About Sigma-Aldrich: Sigma-Aldrich is a leadin...
(Date:11/24/2009)... SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- Shanghai B... Administration (SFDA) has approved the,investigat...lin project,(Nodlin), an innovative insulin formul...Biolaxy to initiate its first phase I clinical stu...ic of high blood glucose and poor,metabolism. The ...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Biolaxy Secures IND Approval for Oral Insulin 2
... the Recently Released Strong Results from the, La...ore Human Appendicitis Blood- ba.... 4 AspenBio Pharma,Inc. (Nasdaq: APPY ) an emer...evelopment of novel drugs and diagnostics for anim... Edgewater Research Investor Conference, scheduled...
...dle (Nasdaq: KNDL ), a,leading, global full-servi... that President and Chief Operating Officer Christ...eichroeder Hidden Gems Conference. The,conference ...ew York City,Oct. 8-9, 2007. Kendle,s presentation...ern Time. (Logo: http://www.newscom.com/cgi-bin/...
... Acquisition Corp. (OTC,Bulletin Board: ACAQ), a s...a definitive agreement to acquire Lumen Medical In...opment stage biotechnology company that is,develop... the diagnosis of,Pulmonary Embolism, Pulmonary Hy...e trade name PulmoBind. Under the terms of the agr...
Other Biology Technology:AspenBio Pharma to Present the Edgewater Research Investor Conference 2Kendle to Present at the Natixis Bleichroeder Hidden Gems Conference 2Acorn Acquisition Corp Announces Definitive Agreement to Acquire Lumen Medical Inc. 2Acorn Acquisition Corp Announces Definitive Agreement to Acquire Lumen Medical Inc. 3Acorn Acquisition Corp Announces Definitive Agreement to Acquire Lumen Medical Inc. 4
Anti-Monocarboxylate Transporter 2 (MCT2) Polyclonal Antibody, Unconjugated from CHEMICON
Mouse Anti-Human Relaxin-2, pro- Monoclonal Antibody, Unconjugated, Clone fred from Immundiagnostik
Rabbit Anti-Chicken IgY, IgG F(ab')2 fragment Antibody, Biotin Conjugated from Biomeda Corporation
Anti-Chloride Channel, CLC-2 Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products: